APA (7th ed.) Citation

Jeyin, N., Kidane, G., Withers, D., Ball, S., & Tarver, K. (2023). Real world experience of hypofractionated radical radiotherapy for non-small cell lung cancer (NSCLC) during the COVID-19 pandemic: A well-tolerated radiotherapy schedule with acceptable progression-free (PFS) and overall survival (OS). Lung cancer (Amsterdam, Netherlands), 178, S63. https://doi.org/10.1016/S0169-5002(23)00572-X

Chicago Style (17th ed.) Citation

Jeyin, Nidhish, Ghirmay Kidane, Dominic Withers, Simon Ball, and Kathryn Tarver. "Real World Experience of Hypofractionated Radical Radiotherapy for Non-small Cell Lung Cancer (NSCLC) During the COVID-19 Pandemic: A Well-tolerated Radiotherapy Schedule with Acceptable Progression-free (PFS) and Overall Survival (OS)." Lung Cancer (Amsterdam, Netherlands) 178 (2023): S63. https://doi.org/10.1016/S0169-5002(23)00572-X.

MLA (9th ed.) Citation

Jeyin, Nidhish, et al. "Real World Experience of Hypofractionated Radical Radiotherapy for Non-small Cell Lung Cancer (NSCLC) During the COVID-19 Pandemic: A Well-tolerated Radiotherapy Schedule with Acceptable Progression-free (PFS) and Overall Survival (OS)." Lung Cancer (Amsterdam, Netherlands), vol. 178, 2023, p. S63, https://doi.org/10.1016/S0169-5002(23)00572-X.